This study, Hypofractionated Radiotherapy in Older Patients with Non-melanoma Skin Cancer: Less is Better, explores how our Xstrahl 300 system was used to successfully treat NMSC for 3 older patients. See the full study here, and more details below.
Xstrahl Announces Landmark Education Program for SARRP Users to Advance Preclinical Radiation Research
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
